Interestingly,
Dayes et al. [18] observed a similar phenomenon when
screening for a randomized trial comparing therapies for
established breast cancer-related lymphedema. Of 437 patients
screened for their study, only 49 met inclusion criteria with
only 24 subjects (5.5%) consenting to protocol therapy.